Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Amortization - Intangibles (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Amortization - Intangibles came in at $155000.0 in Q2 2026, down 34.6% on a YoY basis from $237000.0 in Q2 2025, and little changed quarter-over-quarter from $155000.0 in Q1 2026.

Analysis

Medpace Holdings (MEDP) Amortization - Intangibles (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Amortization - Intangibles for 12 consecutive years, with $155000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization - Intangibles fell 34.6% year-over-year to $155000.0; the trailing twelve-month figure through Jun 2026 stood at $783000.0 (down 34.42% YoY), and the FY2025 full-year result was $946000.0, down 34.44% from the prior year.
  • Amortization - Intangibles was little changed at $155000.0 in Q2 2026 per MEDP's latest filing, from $155000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $838000.0 in Q1 2022 and bottomed at $155000.0 in Q1 2026.
  • Historically, Amortization - Intangibles has averaged $458333.3 across 5 years, with a median of $361000.0 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Amortization - Intangibles tumbled 34.63% in 2025, then tumbled 34.32% in 2026.
  • Over 5 years, Amortization - Intangibles stood at $838000.0 in 2022, then slumped by 34.37% to $550000.0 in 2023, then slumped by 34.36% to $361000.0 in 2024, then plunged by 34.35% to $237000.0 in 2025, then slumped by 34.6% to $155000.0 in 2026.
  • According to Business Quant data, Amortization - Intangibles over the past three periods registered $155000.0, $155000.0, and $237000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 155,000.00
Mar 31, 2026 155,000.00
Dec 31, 2025 237,000.00
Sep 30, 2025 236,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 236,000.00
Dec 31, 2024 361,000.00
Sep 30, 2024 360,000.00
Jun 30, 2024 361,000.00
Mar 31, 2024 361,000.00
Dec 31, 2023 550,000.00
Sep 30, 2023 549,000.00
Jun 30, 2023 550,000.00
Mar 31, 2023 550,000.00
Dec 31, 2022 838,000.00
Sep 30, 2022 838,000.00
Jun 30, 2022 838,000.00
Mar 31, 2022 838,000.00
Dec 31, 2021 1.28 Mn
Sep 30, 2021 1.28 Mn